FindTrial
Sign In

Influence of Intra-abdominal Ropivacaine 0.5% Spray on Postoperative Analgesia in Laparoscopic Surgery.

Influence of Intra-abdominal Ropivacaine 0.5% Spray on Postoperative Analgesia in Laparoscopic Surgery.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05173090
Enrollment
120
Registered
2021-12-29
Start date
2022-01-15
Completion date
2022-07-30
Last updated
2021-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Acute

Brief summary

Assessing postoperative pain after ropivacin 0.5% spray in the abdominal cavity during laparoscopic surgery.

Interventions

DRUGRopivacaïne 0,5% for appendectomy or cholecystectomy surgery

Visual analog scale 15 min after arrival in the recovery room, then H+4, H+6, H+12, H+24 and one week after the operation

Sponsors

University of Liege
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Appendectomy or cholecystectomy surgery

Exclusion criteria

* Allergy to local anesthetics * Intolerance to tramadol HCl * Patient with peritonitis * Pregnant women * Surgery without laparoscopy * Chronic pain before the operation

Design outcomes

Primary

MeasureTime frameDescription
Patient's painDuring appendectomy and cholecystectomy surgeryThe patient's satisfaction was assessed by visual analog scale, ranging from one (worse outcome )to four (better outcome

Contacts

Primary ContactBenjamin Javillier, MD
javillier.benjamin@hotmail.com+32498573882

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026